Matched cohort study by Public Health England suggests not a large difference in outcomes between 501Y.V1 cases and wildtype cases.
However, number of outcomes recorded is small.
Mutations in 501Y.V2 circulating in South Africa impact antibody binding (501Y.V1 in the UK is less of a concern)
I still expect 2021 to bring the pandemic under control through vaccination and natural infection, but perhaps with a rockier start than I had imagined just 3 weeks ago.